CDH1 and pancreatic neoplasm: Collectively, these results indicated that circ_0013587 sponges miR-1227 to enhance E-cadherin level, in turn attenuating the acquired resistance to erlotinib and invasive ability of pancreatic cancer cells (Figure 8C).